San Diego, CA, United States of America

Andrea Fanjul

This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignees: Incyte San Diego Inc., Ortho-Mcneil Pharmaceutical Corp., Takeda Pharmaceutical Company Limited. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrea Fanjul. Retrieved from https://idiyas.com/inventor/andrea-fanjul

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 37.5

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2003-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Journey of Andrea Fanjul

Introduction: Andrea Fanjul, a pioneering inventor based in San Diego, CA, has made significant contributions to the world of technology with her groundbreaking innovations.

Latest Patents: Andrea Fanjul's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time.

Career Highlights: Throughout her illustrious career, Andrea Fanjul has been recognized for her inventive spirit, receiving multiple awards for her innovative solutions in the fields of biotechnology and sustainable energy.

Collaborations: Andrea Fanjul has collaborated with leading research institutions and universities to further develop her inventions, showcasing her commitment to pushing the boundaries of technological advancement.

Conclusion: Andrea Fanjul's dedication to innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors, solidifying her legacy as a trailblazer in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…